BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Stevens NE, Cowin AJ, Kopecki Z. Skin Barrier and Autoimmunity-Mechanisms and Novel Therapeutic Approaches for Autoimmune Blistering Diseases of the Skin. Front Immunol 2019;10:1089. [PMID: 31156638 DOI: 10.3389/fimmu.2019.01089] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Thangavelu G, Bolivar-wagers S, Aguilar EG, Rhee SY, Koehn BH, Hippen KL, Blazar BR. Insights and strategies to promote immune tolerance in allogeneic hematopoietic stem cell transplantation recipients. Translational Autoimmunity 2023. [DOI: 10.1016/b978-0-323-85389-7.00017-x] [Reference Citation Analysis]
2 Tampa M, Neagu M, Caruntu C, Constantin C, Georgescu SR. Skin Inflammation—A Cornerstone in Dermatological Conditions. JPM 2022;12:1370. [DOI: 10.3390/jpm12091370] [Reference Citation Analysis]
3 Belheouane M, Hermes BM, Van Beek N, Benoit S, Bernard P, Drenovska K, Gerdes S, Gläser R, Goebeler M, Günther C, von Georg A, Hammers CM, Holtsche MM, Homey B, Horváth ON, Hübner F, Linnemann B, Joly P, Márton D, Patsatsi A, Pföhler C, Sárdy M, Huilaja L, Vassileva S, Zillikens D, Ibrahim S, Sadik CD, Schmidt E, Baines JF. Characterization of the skin microbiota in bullous pemphigoid patients and controls reveals novel microbial indicators of disease. J Adv Res 2023;44:71-9. [PMID: 35581140 DOI: 10.1016/j.jare.2022.03.019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Kutasevych Y, Abdalla A, Oliinyk I, Mashtakova I, Shcherbakova Y. RETROSPECTIVE CHART ANALYSIS OF PATIENTS DIGNOSED WITH ACANTHOLYTIC PEMPHIGUS FOR THE PERIOD 2008-2018. Wiad Lek 2022;75:416-421. [DOI: 10.36740/wlek202202116] [Reference Citation Analysis]
5 Deotto ML, Spiller A, Sernicola A, Alaibac M. Bullous pemphigoid: An immune disorder related to aging (Review). Exp Ther Med 2022;23:50. [PMID: 34934428 DOI: 10.3892/etm.2021.10972] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
6 Braegelmann C, Niebel D, Wenzel J. Targeted Therapies in Autoimmune Skin Diseases. J Invest Dermatol 2021:S0022-202X(21)02287-9. [PMID: 34756580 DOI: 10.1016/j.jid.2021.08.439] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Kutasevych Y, Dzhoraieva S, Goncharenko V, Maschtakova I, Shchogoleva H, Sobol N. STUDY OF INDICATORS OF ANTIMICROBIAL RESISTANCE IN PATIENTS WITH ALLERGODERMATOSIS, СОMPLICATED BY STAPHYLOCOCCUS INFECTION, ACCORDING TO THE RESULTS OF TESTS WITH AUTOSTRAINS. Journal NAMSU 2021. [DOI: 10.37621/10.37621/jnamsu-2021-2-1] [Reference Citation Analysis]
8 Bishnoi A, De D, Handa S, Mahajan R. Biologics in autoimmune bullous diseases: Current scenario. Indian J Dermatol Venereol Leprol 2021;87:611-20. [PMID: 34245525 DOI: 10.25259/IJDVL_886_19] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
9 Patel PM, Jones VA, Behnam CT, Zenzo GD, Amber KT. A Review of Acquired Autoimmune Blistering Diseases in Inherited Epidermolysis Bullosa: Implications for the Future of Gene Therapy. Antibodies (Basel) 2021;10:19. [PMID: 34067512 DOI: 10.3390/antib10020019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
10 Belheouane M, Hermes BM, Van Beek N, Benoit S, Bernard P, Drenovska K, Gerdes S, Gläser R, Goebeler M, Günther C, von Georg A, Hammers CM, Holtsche MM, Homey B, Horváth ON, Hübner F, Linnemann B, Joly P, Márton D, Patsatsi A, Pföhler C, Sárdy M, Huilaja L, Vassileva S, Zillikens D, Ibrahim S, Sadik CD, Schmidt E, Baines JF. Characterization of the skin microbiota in bullous pemphigoid patients and controls reveals novel microbial indicators of disease.. [DOI: 10.1101/2021.04.30.21256380] [Reference Citation Analysis]
11 Rekvig OP. Autoimmunity and SLE: Factual and Semantic Evidence-Based Critical Analyses of Definitions, Etiology, and Pathogenesis. Front Immunol 2020;11:569234. [PMID: 33123142 DOI: 10.3389/fimmu.2020.569234] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
12 Bobrowicz M, Zagozdzon R, Domagala J, Vasconcelos-Berg R, Guenova E, Winiarska M. Monoclonal Antibodies in Dermatooncology-State of the Art and Future Perspectives. Cancers (Basel) 2019;11:E1420. [PMID: 31554169 DOI: 10.3390/cancers11101420] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
13 Roesner LM, Werfel T. Autoimmunity (or Not) in Atopic Dermatitis. Front Immunol 2019;10:2128. [PMID: 31552053 DOI: 10.3389/fimmu.2019.02128] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 5.3] [Reference Citation Analysis]